Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non–Vitamin K Antagonist Oral Anticoagulant Trials

M Proietti, E Guiducci, P Cheli, GYH Lip - Stroke, 2017 - Am Heart Assoc
Background and Purpose—Obesity is a risk factor for all-cause and cardiovascular death
but, despite this, an inverse relationship between overweight or obesity and a better …

Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials

M Proietti, E Guiducci, P Cheli, GYH Lip - Stroke, 2017 - pubmed.ncbi.nlm.nih.gov
Background and purpose Obesity is a risk factor for all-cause and cardiovascular death but,
despite this, an inverse relationship between overweight or obesity and a better …

Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials

M Proietti, E Guiducci, P Cheli, GYH Lip - STROKE, 2017 - air.unimi.it
BACKGROUND AND PURPOSE: Obesity is a risk factor for all-cause and cardiovascular
death but, despite this, an inverse relationship between overweight or obesity and a better …

Is there an obesity paradox for outcomes in atrial fibrillation? A systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant trials.

M Proietti, E Guiducci, P Cheli, GYH Lip - 2017 - cabidigitallibrary.org
Abstract Background and Purpose-Obesity is a risk factor for all-cause and cardiovascular
death but, despite this, an inverse relationship between overweight or obesity and a better …

Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials

M PROIETTI, E Guiducci, P Cheli, GYH Lip - STROKE, 2017 - iris.uniroma1.it
BACKGROUND AND PURPOSE: Obesity is a risk factor for all-cause and cardiovascular
death but, despite this, an inverse relationship between overweight or obesity and a better …

Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials.

M Proietti, E Guiducci, P Cheli, GY Lip - Stroke, 2017 - europepmc.org
Background and purpose Obesity is a risk factor for all-cause and cardiovascular death but,
despite this, an inverse relationship between overweight or obesity and a better …

Is There an Obesity Paradox for Outcomes in Atrial Fibrillation?: A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials

M Proietti, E Guiducci, P Cheli, GYH Lip - Stroke, 2017 - vbn.aau.dk
BACKGROUND AND PURPOSE: Obesity is a risk factor for all-cause and cardiovascular
death but, despite this, an inverse relationship between overweight or obesity and a better …

Is There an Obesity Paradox for Outcomes in Atrial Fibrillation?

Stroke, 2017 - Am Heart Assoc
Background and Purpose—Obesity is a risk factor for all-cause and cardiovascular death
but, despite this, an inverse relationship between overweight or obesity and a better …

[PDF][PDF] Is There an Obesity Paradox for Outcomes in Atrial Fibrillation?

Stroke, 2017 - air.unimi.it
Background and Purpose—Obesity is a risk factor for all-cause and cardiovascular death
but, despite this, an inverse relationship between overweight or obesity and a better …

Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials

M PROIETTI, E Guiducci, P Cheli, GYH Lip - STROKE, 2017 - iris.uniroma1.it
BACKGROUND AND PURPOSE: Obesity is a risk factor for all-cause and cardiovascular
death but, despite this, an inverse relationship between overweight or obesity and a better …